Instil Bio, Inc. is a U.S.-based biotechnology company headquartered in Massachusetts, specializing in the development and production of advanced immunotherapies for cancer treatment. The company utilizes cutting-edge T-cell modification technologies to enhance the efficacy of immunotherapy and improve treatment outcomes for patients with various types of cancer. Instil Bio collaborates with academic and industrial partners and focuses on developing innovative and personalized approaches in the field of oncology immunotherapy.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
